IFNAR2 and hematocrit: We analyzed the percentage of CD4+ IL17A+, CD4+ IFN-r+, CD4+ IL4+ T cells and CD4+ CD25+ Tregs in the total number of CD4+ T cells from peripheral blood of 30 patients with HT and 30 healthy control participants (HC) by flow cytometry.